The ReTain study at the Oxford Health Clinical Research Facility (OH CRF) is looking for volunteers aged 55-75 without a memory condition to evaluate the safety and effectiveness of an immunotherapy treatment in slowing the progression of Alzheimer’s Disease.

Participation involves:

• 22 clinic visits and 4 phone calls over 4 years
• Completion of a participant diary
• Scans
• Cognitive tests

Recruitment to the study is open until December 2026.

Those with a diagnosis of Alzheimer’s Dementia or non-Alzheimer’s Dementia would not be eligible to participate.

Those with history or current neurological disease would not be eligible to participate.

To learn more, contact Dementia.Research@oxfordhealth.nhs.uk today